Editorial: Oral therapy in diabetes mellitus.
D000092:Acetohexamide / Q000008:administration & dosage; D001645:Biguanides / Q000627:therapeutic use*; D002747:Chlorpropamide / Q000008:administration & dosage; D003920:Diabetes Mellitus / Q000188:drug therapy*; D016883:Diabetic Ketoacidosis / Q000139:chemically induced; D004035:Diet Therapy; D006801:Humans; D007003:Hypoglycemia / Q000139:chemically induced; D007004:Hypoglycemic Agents / Q000627:therapeutic use*; D007773:Lactates / Q000097:blood; D010629:Phenformin / Q000009:adverse effects; D010919:Placebos; D011773:Pyruvates / Q000097:blood; D013453:Sulfonylurea Compounds / Q000009:adverse effects / Q000627:therapeutic use*; D014042:Tolazamide / Q000008:administration & dosage; D014044:Tolbutamide / Q000008:administration & dosage; D014435:Typhoid Fever / Q000188:drug therapy
D001645:Biguanides; D007004:Hypoglycemic Agents; D007773:Lactates; D010919:Placebos; D011773:Pyruvates; D013453:Sulfonylurea Compounds; D014044:Tolbutamide; D014042:Tolazamide; D010629:Phenformin; D000092:Acetohexamide; D002747:Chlorpropamide